Intravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab
AIM: To report the change in visual acuity and central macular thickness (CMT) following treatment with intravitreal aflibercept injections in patients with neovascular age-related macular degeneration (nAMD) with suboptimum response to ranibizumab. METHODS: This was a retrospective study. The incl...
Gorde:
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Press of International Journal of Ophthalmology (IJO PRESS)
2017-03-01
|
| Saila: | International Journal of Ophthalmology |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360778/ |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|